Photocure ASA: Renewal of market maker agreement
Oslo, Norway, 5 April 2013: Photocure ASA (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies in dermatology and cancer, announces that its market maker agreement with SpareBank1 Markets will be replaced with a similar market maker agreement with DNB Markets with effect as of 21 May 2013.
For further information, please contact:
CFO Erik Dahl
Tel: +47 50 55 000, Email: firstname.lastname@example.org